Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection

  • Protocol
  • Intervention

Authors

  • Tim J Benstead,

    Corresponding author
    1. Dalhousie University, Department of Medicine, Division of Neurology, Halifax, Nova Scotia, Canada
    • Tim J Benstead, Department of Medicine, Division of Neurology, Dalhousie University, Room 3828 Halifax Infirmary, 1796 Summer Street, Halifax, Nova Scotia, B3H 3A7, Canada. tbenstea@dal.ca.

    Search for more papers by this author
  • Colin H Chalk,

    1. McGill University, Departments of Medicine and Neurology & Neurosurgery, Montreal, Quebec, Canada
    Search for more papers by this author
  • Natalie E Parks

    1. Dalhousie University, Department of Medicine, Division of Neurology, Halifax, Nova Scotia, Canada
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of interventions (including interferon α, interferon α plus ribavirin, corticosteroids, cyclophosphamide, plasma exchange, and rituximab) for cryoglobulinemic or non-cryoglobulinemic peripheral neuropathy associated with HCV infection.